Supporting Caregivers Behind Youth with T1D: A Systematic Review of Psychosocial Interventions and Youth Glycemic Outcomes.

Curr Diab RepSep 30, 2026 (epub)
Clinical ResearchEndocrinologyPediatricsOpen access

Vasco Costa, Bárbara Pereira, Nadia de Maio et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review analyzed 26 studies on psychosocial interventions for parents of children with Type 1 Diabetes (T1D) from 2019 to 2025. The review found that these interventions, primarily based on cognitive-behavioral frameworks, are linked to improvements in various parental psychosocial factors, although glycemic outcomes showed variability across studies.

Key findings

  • Interventions improved parental psychosocial factors such as diabetes distress and quality of life.
  • Glycemic outcomes were heterogeneous across the studies reviewed.
  • Most interventions utilized cognitive-behavioral frameworks and diverse delivery formats.
  • The evidence base reflects both heterogeneity and potential for adaptation in different contexts.

Why it matters

Understanding the impact of psychosocial interventions on caregivers can enhance support for families managing Type 1 Diabetes, potentially leading to better overall health outcomes for youth. Improved parental mental health may indirectly benefit glycemic control.

Source

PubMed · PMID 42814156Free full text on PubMed Central

Published in Curr Diab Rep. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Endocrinology

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.